Market Cap | 62.33M | P/E | 14.18 | EPS this Y | 136.70% | Ern Qtrly Grth | 5.70% |
Income | 2.13M | Forward P/E | 12.12 | EPS next Y | 5.60% | 50D Avg Chg | -6.00% |
Sales | 53.84M | PEG | - | EPS past 5Y | -0.72% | 200D Avg Chg | 1.00% |
Dividend | N/A | Price/Book | 2.41 | EPS next 5Y | - | 52W High Chg | -18.00% |
Recommedations | - | Quick Ratio | 1.61 | Shares Outstanding | 3.36M | 52W Low Chg | 21.00% |
Insider Own | 34.90% | ROA | 8.60% | Shares Float | 1.83M | Beta | 0.38 |
Inst Own | 26.76% | ROE | 6.81% | Shares Shorted/Prior | 5.52K/3.43K | Price | 17.58 |
Gross Margin | 27.02% | Profit Margin | 3.95% | Avg. Volume | 3,314 | Target Price | 30.00 |
Oper. Margin | 15.65% | Earnings Date | Oct 31 | Volume | 4,231 | Change | -2.33% |
Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.
Ascendiant Capital | Buy | Sep 9, 24 |
Ascendiant Capital | Buy | Jan 4, 17 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
Van Kirk Richard Lee Jr | Chief Executive Offi.. Chief Executive Officer | Aug 30 | Option | 1.73 | 5,000 | 8,650 | 88,196 | 09/01/22 |